Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States

By sjmartinez • January 7, 2023

Nicholas SB, Alicic RZ, Shen J. Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States. Kidney Med. 2022 Dec 15;5(1):100590. doi: 10.1016/j.xkme.2022.100590. PMID: 36605084; PMCID: PMC9807823.

Tags: Harbor UCLA, Nephrology, Publications

Rapid and reliable diagnosis of mucormycosis using colorimetric loop-mediated isothermal amplification

Gu Y, Ibrahim BA, Gebremariam T, Alkhazraji S, Aerts R, Vanbiervliet Y, Lagrou K, Maertens J, Prattes J, Egger M, Dichtl K, Jenks JD, Hoenigl[...]

Dietary potassium and fiber intake, survival, and health-related quality of life, in a prospective multi-center hemodialysis cohort

Narasaki Y, Li Z, Ong M, Siu MKM, Han SH, Chang TI, Cervantes MK, You AS, Novoa A, Le L, Nguyen DV, Kalantar-Zadeh K, Rhee[...]

Selectivity Modulation of Small Cationic Membrane-Active Cyclic Peptides with Broad-Spectrum Activity against Bacteria and Fungi

Lohan S, Tiwari RK, Maslennikov I, Das Gupta K, Singh S, Parang K. Selectivity Modulation of Small Cationic Membrane-Active Cyclic Peptides with Broad-Spectrum Activity against[...]